Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease intestinal disease
Comorbidity C0007114|skin cancer
Sentences 7
PubMedID- 20005977 Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease.
PubMedID- 22584081 Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease.
PubMedID- 24183955 Avoiding rash decision making: skin cancer screening of patients with inflammatory bowel disease.
PubMedID- 21806945 Increased risk of nonmelanoma skin cancers among individuals with inflammatory bowel disease.
PubMedID- 24419479 Association between thiopurine use and nonmelanoma skin cancers in patients with inflammatory bowel disease: a meta-analysis.
PubMedID- 24193153 Background: several studies have demonstrated an increased risk of nonmelanoma skin cancer (nmsc) in patients with inflammatory bowel disease, with the greatest risk in patients with crohn's disease (cd).
PubMedID- 21296187 Risk of nonmelanoma skin cancer in patients with inflammatory bowel disease who use thiopurines is not increased.

Page: 1